🔴 SKIN is trading 6.3% down today on profit-taking after FDA-driven surge

SKIN is trading 6.3% down at $1.04 as the stock undergoes a pre-market pullback following a significant FDA-driven rally.

• The stock surged 47.04% to $1.11 on July 07, 2026, after receiving FDA clearance for its SkinStylus SteriLock MicroSystem wrinkle treatment system.
• Today's decline appears to be normal profit-taking following the outsized move and regulatory milestone achieved in the prior session.